DOMINICI, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 44.350
AS - Asia 22.937
EU - Europa 22.767
SA - Sud America 3.369
AF - Africa 583
OC - Oceania 117
Continente sconosciuto - Info sul continente non disponibili 30
Totale 94.153
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 43.297
SG - Singapore 6.832
IT - Italia 6.449
CN - Cina 5.692
GB - Regno Unito 4.904
SE - Svezia 3.433
HK - Hong Kong 2.725
VN - Vietnam 2.561
BR - Brasile 2.453
DE - Germania 2.038
BD - Bangladesh 1.178
FI - Finlandia 1.111
RU - Federazione Russa 936
FR - Francia 792
KR - Corea 705
TR - Turchia 621
UA - Ucraina 615
CA - Canada 575
IN - India 550
IE - Irlanda 537
ID - Indonesia 501
AR - Argentina 325
NL - Olanda 322
JP - Giappone 295
MX - Messico 295
BG - Bulgaria 293
PL - Polonia 187
ES - Italia 184
ZA - Sudafrica 172
BE - Belgio 171
IQ - Iraq 171
PK - Pakistan 143
AT - Austria 126
AE - Emirati Arabi Uniti 119
EC - Ecuador 117
AU - Australia 111
CO - Colombia 107
CL - Cile 105
VE - Venezuela 104
MY - Malesia 96
LT - Lituania 92
CZ - Repubblica Ceca 84
RO - Romania 81
MA - Marocco 75
UZ - Uzbekistan 68
KE - Kenya 67
TW - Taiwan 65
PH - Filippine 64
EG - Egitto 63
CH - Svizzera 62
IR - Iran 59
SA - Arabia Saudita 57
JO - Giordania 55
PE - Perù 49
PY - Paraguay 48
AL - Albania 46
DZ - Algeria 44
IL - Israele 44
NO - Norvegia 44
TN - Tunisia 43
TH - Thailandia 37
NP - Nepal 36
PT - Portogallo 33
SI - Slovenia 30
UY - Uruguay 30
AZ - Azerbaigian 27
LB - Libano 27
RS - Serbia 27
CR - Costa Rica 25
JM - Giamaica 25
KZ - Kazakistan 25
DO - Repubblica Dominicana 24
BO - Bolivia 23
OM - Oman 23
BY - Bielorussia 22
DK - Danimarca 19
HR - Croazia 19
SY - Repubblica araba siriana 19
ET - Etiopia 18
GR - Grecia 18
SN - Senegal 18
EU - Europa 16
QA - Qatar 16
SK - Slovacchia (Repubblica Slovacca) 16
CY - Cipro 15
HN - Honduras 15
NG - Nigeria 14
PA - Panama 14
EE - Estonia 13
GT - Guatemala 13
HU - Ungheria 13
AM - Armenia 12
BZ - Belize 12
CI - Costa d'Avorio 12
KG - Kirghizistan 12
PS - Palestinian Territory 12
GE - Georgia 11
BA - Bosnia-Erzegovina 10
BH - Bahrain 10
LK - Sri Lanka 10
Totale 93.929
Salva come PNG Salva come JPEG
Città #
Ashburn 4.836
Singapore 4.369
Santa Clara 3.894
Fairfield 3.778
Southend 2.717
Hong Kong 2.645
Chandler 2.271
Woodbridge 1.979
San Jose 1.884
Stockholm 1.834
Hefei 1.784
Houston 1.596
Seattle 1.373
Wilmington 1.198
Cambridge 1.173
Council Bluffs 1.133
Ann Arbor 1.111
Beijing 1.055
London 1.049
Los Angeles 989
Nyköping 976
Jacksonville 965
Ho Chi Minh City 859
Chicago 855
Dearborn 851
Helsinki 836
New York 834
Modena 720
Seoul 659
Hanoi 612
Dallas 584
The Dalles 584
Milan 551
Munich 524
Dublin 500
Bologna 499
San Diego 432
Jakarta 361
Salt Lake City 319
Lauterbourg 318
Izmir 308
Princeton 304
Buffalo 294
Moscow 294
Shanghai 283
Sofia 277
Rome 257
Frankfurt am Main 242
São Paulo 222
Tokyo 215
Eugene 198
Orem 183
Boardman 170
Parma 157
Tampa 153
Phoenix 151
Elk Grove Village 150
Reggio Emilia 139
Warsaw 137
Toronto 130
Redwood City 129
Berlin 125
Des Moines 125
Columbus 123
Brussels 122
Montreal 120
Nuremberg 120
Falls Church 119
Mexico City 118
Atlanta 117
Bremen 114
Mcallen 109
Fremont 108
Guangzhou 108
Da Nang 105
Chennai 103
Montréal 103
Amsterdam 101
Johannesburg 101
Brooklyn 99
Naples 98
Denver 97
Rio de Janeiro 97
Lancaster 95
Haiphong 88
Kent 87
Manchester 86
Miami 77
Redondo Beach 76
Florence 73
Sterling 71
Turku 64
Poplar 63
San Francisco 63
Vienna 63
Portsmouth 61
Dong Ket 60
Hillsboro 60
Mumbai 60
Baghdad 59
Totale 63.538
Salva come PNG Salva come JPEG
Nome #
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. 2.214
0.1 grams of sub-cutaneous adipose tissue (SCAT) as source of adult multipotent mesenchymal stromal cells (MSC) for cell-based therapies 711
Dynamic cultivation of mesenchymal stem cell aggregates 657
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement 573
CD271 Mediates Stem Cells to Early Progeny Transition in Human Epidermis 496
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy 474
Impressive response to dose-dense chemotherapy in a patient with NUT midline carcinoma 472
Rigenerand srl - Spin off Università di Modena e Reggio Emilia 434
Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance. 429
GD2 expression in breast cancer. 426
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 423
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 421
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 419
Autologous Porcine Bone Marrow Mesenchymal Cells for Reconstruction of a Resorbed Alveolar Bone: A Preclinical Model in Mini-Pigs 418
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome 408
GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion. 407
Microglia are less pro-inflammatory than myeloid infiltrates in the hippocampus of mice exposed to status epilepticus 402
The puzzling situation of hospital exemption for advanced therapy medicinal products in Europe and stakeholders' concerns 398
Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients 396
Delayed marrow infusion in mice enhances hematopoietic and osteopoietic engraftment by facilitating transient expansion of the osteoblastic niche 395
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies 393
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing 391
MSC and Tumors: Homing, Differentiation and Secretion Influence The Therapeutic Potentials 389
Interstitial Lung Disease in Abemaciclib-treated Patients during SARS-CoV-2 Pandemic: A Case Series. 386
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 380
Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood 380
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 379
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity 377
Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells 377
cGMP-compliant transportation conditions for a prompt therapeutic use of marrow mesenchymal stromal/stem cells 375
Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT) 372
Phase I study of intraperitoneal MHC unrestricted adoptive cell therapy with TALL-104 cells in patients with peritoneal carcinosis 371
Le Cellule Staminali Mesenchimali: Aspetti Biologici ed Approcci Terapeutici 368
A novel function for amniotic fluid: original or authentic? 367
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors 367
In vitro differentiation of human amniotic epithelial cells into insulin-producing 3D spheroids 367
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance 364
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 362
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 361
Mesenchymal progenitors aging highlights a mir-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis 354
Transportation conditions for prompt use of Ex Vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration 354
Clarification of the nomenclature for MSC: the international society for cellular therapy position statement 351
PCR con primer degenerati non evidenzia sequenze virali di HHV-8 ne di una sua variante in cellule stromali midollari di pazienti affetti da gammopatie monoclonali 351
Body composition and inflammation impact in non-small cell lung cancer patients treated by first-line immunotherapy 351
An alternative approach to investigate biofilm in medical devices: A feasibility study 350
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM 348
Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy 345
Potency biomarker signature genes from multiparametric osteogenesis assays: Will cGMP human bone marrow mesenchymal stromal cells make bone? 343
Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study. 341
Osteopoietic engraftment after bone marrow transplantation: Effect of inbred strain of mice 339
Transplanted murine long-term repopulating hematopoietic cells can differentiate to osteoblasts in the marrow stem cell niche 338
Integrated intErventional bronchoscopy in the treatment of locally adVanced non-small lung cancER with central Malignant airway Obstructions: a multicentric REtrospective study (EVERMORE). 338
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 336
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 336
International society for cellular therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials 335
Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria 333
Nivolumab-Induced Impressive Response of Refractory Pulmonary Sarcomatoid Carcinoma with Brain Metastasis 333
Comparison of single and dual platform methodologies for the estimation of CD34+ hematopoietic progenitor cells: correlation with colony assay 332
Human mesenchymal stem cell combined with a new strontium-enriched bioactive glass: An ex-vivo model for Bone Regeneration 332
Tumor Stroma Manipulation By MSC 331
ALDH Expression in Angiosarcoma of the Lung: A Potential Marker of Aggressiveness? 328
Cancer stem-neuroendocrine cells in an atypical carcinoid case report. 327
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells. 326
METHOD FOR PRODUCTION OF ANTI-TUMOR TRAIL PROTEIN 324
Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come? 324
Label-free toxicology screening of primary human mesenchymal cells and iPS-derived neurons 321
A new bioactive glass with extremely high crystallization temperature and outstanding biological performance 320
Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression 318
Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial 317
Expression of HOXB7 in the lung of patients with idiopathic pulmonary fibrosis: a proof of concept study. 316
Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation 316
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 316
Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study 315
Cytokine-Induced Osteopoietic Differentiation of Transplanted Marrow Cells 314
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis 314
Detection of microparticles from human red blood cells by multiparametric flow cytometry 313
Inhibiting interactions of lysine demethylase LSD1 with Snail/Slug blocks cancer cell invasion. 311
Thromboembolism (TE) and adjuvant endocrine therapy (AET) in hormone receptor positive (HR+) early breast cancer (EBC): Did the evolution of treatment change the incidence of the adverse event? A metanalysis 311
Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development. 309
Angiogenesis in multiple myeloma: Correlation between in vitro endothelial colony growth (CFU-En) and clinical biological features 308
Assessing biocompatibility of face mask materials during covid-19 pandemic by a rapid multi-assays strategy 308
Mineralization by mesenchymal stromal cells is variously modulated depending on commercial platelet lysate preparations 305
The phenotypes of microglia and macrophages during epileptogenesis 304
How do mesenchymal stromal cells exert their therapeutic benefit? 302
Transgenic Mice with Pancellular Enhanced Green Fluorescent Protein Expression in Primitive Hematopoietic Cells and All Blood Cell Progeny 302
Basic research and clinical applications of non-hematopoietic stem cells, 4-5 April 2008, Tubingen, Germany. 301
Predictors of HER2 gene amplification in immunohistochemistry score 2+ Early Breast Cancer according to 2018 ASCO/CAP guidelines: a single institution analysis. 300
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma 300
Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. 299
Progress in characterization, preparation and clinical applications of non-hematopoietic stem cells, 29-30 September 2006, Tübingen, Germany 298
Understanding Tumor-Stroma Interplays for Targeted Therapies by Armed Mesenchymal Stromal Progenitors: The Mesenkillers. 297
Cell therapy for disorders of bone 296
Cell therapies for pancreatic beta-cell replenishment. 295
Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning 295
Precision Medicine in Lung Cancer: Challenges and Opportunities in Diagnostic and Therapeutic Purposes. 295
Rare breast cancer subtypes: Histological, molecular, and clinical peculiarities 294
Mesenchymal Stromal/Stem Cells from Tissue Repair to Destruction of Tumor Cells 293
Donor Cell-Derived Osteopoiesis Originates from a Self-Renewing Stem Cell with a Limited Regenerative Contribution after Transplantation 293
Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players. 292
GD2 CAR T cells against human glioblastoma 292
Totale 37.579
Salva come PNG Salva come JPEG
Categoria #
all - tutte 362.956
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 362.956
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021431 0 0 0 0 0 0 0 0 0 0 0 431
2021/20226.640 365 734 580 346 282 474 400 409 650 523 1.072 805
2022/20237.287 820 782 539 662 740 904 190 654 1.158 135 404 299
2023/20245.113 257 309 365 493 819 500 512 599 154 196 287 622
2024/202516.779 494 224 488 1.142 2.687 2.480 1.410 980 1.960 1.130 1.619 2.165
2025/202638.287 2.332 1.399 3.046 4.285 5.750 2.165 4.223 1.801 5.055 3.549 2.701 1.981
Totale 94.911